Lexicon Pharmaceuticals (LXRX) Operating Income: 2009-2011
Historic Operating Income for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$114.1 million.
- Lexicon Pharmaceuticals' Operating Income fell 48.68% to -$33.3 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$114.1 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of -$114.1 million for FY2011, which is 19.20% down from last year.
- As of FY2011, Lexicon Pharmaceuticals' Operating Income stood at -$114.1 million, which was down 19.20% from -$95.7 million recorded in FY2010.
- Over the past 5 years, Lexicon Pharmaceuticals' Operating Income peaked at -$90.0 million during FY2009, and registered a low of -$114.1 million during FY2011.
- Its 3-year average for Operating Income is -$99.9 million, with a median of -$95.7 million in 2010.
- Data for Lexicon Pharmaceuticals' Operating Income shows a maximum YoY declined of 19.20% (in 2011) over the last 5 years.
- Over the past 3 years, Lexicon Pharmaceuticals' Operating Income (Yearly) stood at -$90.0 million in 2009, then declined by 6.41% to -$95.7 million in 2010, then declined by 19.20% to -$114.1 million in 2011.